Keywords:
Antifungal agent; acute myeloid leukemia; hematology; mycology; systemic mycosis; Antifungal Agents; Invasive Fungal Infections; Leukemia, Myeloid, Acute
Abstract:
Invasive fungal disease (IFD) remains a common and serious complication in children treated for leukaemia. Antifungal prescription in children with leukaemia presents unique challenges, particularly due to variation in IFD risk between and within leukaemia treatment protocols, drug toxicities and interactions between antifungals and chemotherapeutic agents.